Adial Pharmaceuticals Correlations
| ADILWDelisted Stock | USD 0.01 0 52.50% |
The current 90-days correlation between Adial Pharmaceuticals and Entera Bio is -0.02 (i.e., Good diversification). The correlation of Adial Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Adial Pharmaceuticals Correlation With Market
Good diversification
The correlation between Adial Pharmaceuticals WT and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals WT and DJI in the same portfolio, assuming nothing else is changed.
Adial |
Moving together with Adial Stock
| 0.66 | SHG | Shinhan Financial | PairCorr |
| 0.79 | EC | Ecopetrol SA ADR | PairCorr |
| 0.65 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.67 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.77 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.61 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
Moving against Adial Stock
| 0.84 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.82 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.8 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.75 | WMT | Walmart Aggressive Push | PairCorr |
| 0.74 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.71 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.69 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.69 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.69 | HPQ | HP Inc | PairCorr |
| 0.58 | XOM | Exxon Mobil Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.57 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
| 0.5 | KB | KB Financial Group | PairCorr |
| 0.47 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.46 | VFS | VinFast Auto | PairCorr |
| 0.39 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
Related Correlations Analysis
| 0.29 | 0.4 | 0.29 | 0.66 | ENTXW | ||
| 0.29 | 0.55 | -0.01 | 0.45 | ARTLW | ||
| 0.4 | 0.55 | 0.36 | 0.43 | IMACW | ||
| 0.29 | -0.01 | 0.36 | 0.33 | CREXW | ||
| 0.66 | 0.45 | 0.43 | 0.33 | BCDAW | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Adial Stock performing well and Adial Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Adial Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ENTXW | 37.20 | 5.71 | 0.19 | 0.61 | 30.23 | 135.48 | 266.82 | |||
| ARTLW | 23.23 | 2.91 | 0.09 | (1.93) | 23.45 | 68.38 | 147.53 | |||
| IMACW | 45.76 | 16.91 | 0.44 | (6.39) | 26.50 | 166.67 | 707.09 | |||
| CREXW | 42.58 | 10.60 | 0.33 | 1.39 | 27.59 | 135.71 | 370.19 | |||
| BCDAW | 17.63 | 1.62 | 0.06 | 3.01 | 18.27 | 57.25 | 139.50 |
Adial Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adial Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Adial Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Adial Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Still Interested in Adial Pharmaceuticals WT?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.